Zimbabwe
May 27, 2021
Article: Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis Published in: N Engl J Med. 2021;384(18):1705-1718. https://www.nejm.org/doi/full/10.1056/NEJMoa2033400 Authors: Dorman SE, Nahid P, Kurbatova EV, et al. Summary: The Tuberculosis...
May 13, 2021
Takamiya M, Takarinda K, Balachandra S, et al. Isoniazid preventive therapy use among adult people living with HIV in Zimbabwe. International Journal of STD & AIDS. May 2021. doi:10.1177/09564624211014404 Abstract We assessed the prevalence of isoniazid preventive...
May 10, 2021
Andrea Low, Chloe Teasdale, Kristin Brown, Danielle T Barradas, Owen Mugurungi, Karam Sachathep, Harriet Nuwagaba-Biribonwoha, Sehin Birhanu, Andrew Banda, Koen Frederix, Danielle Payne, Elizabeth Radin, Lubbe Wiesner, Choice Ginindza, Neena Philip, Godfrey Musuka,...
Apr 29, 2021
Article: Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT...
Apr 12, 2021
Correa-Agudelo, Esteban, et al. “Associated Health and Social Determinants of Mobile Populations across HIV Epidemic Gradients in Southern Africa.” Journal of Migration and Health, Elsevier, 26 Mar. 2021, www.sciencedirect.com/science/article/pii/S2666623521000052....